Geode Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $296M | Buy |
1,305,738
+44
| +0% | +$7.83K | 0.02% | 644 |
|
|
2026
Q1 | $225M | Buy |
1,305,694
+29,192
| +2% | +$5.41M | 0.01% | 684 |
|
|
2025
Q4 | $254M | Buy |
1,276,502
+9,756
| +0.8% | +$1.77M | 0.02% | 635 |
|
|
2025
Q3 | $198M | Buy |
1,266,746
+34,516
| +3% | +$5.48M | 0.01% | 705 |
|
|
2025
Q2 | $187M | Sell |
1,232,230
-31,435
| -2% | -$4.19M | 0.01% | 692 |
|
|
2025
Q1 | $190M | Buy |
1,263,665
+30,454
| +2% | +$5.11M | 0.01% | 653 |
|
|
2024
Q4 | $227M | Buy |
1,233,211
+14,787
| +1% | +$2.85M | 0.02% | 593 |
|
|
2024
Q3 | $239M | Buy |
1,218,424
+1,631
| +0.1% | +$339K | 0.02% | 577 |
|
|
2024
Q2 | $251M | Buy |
1,216,793
+30,949
| +3% | +$7.01M | 0.02% | 522 |
|
|
2024
Q1 | $320M | Buy |
1,185,844
+39,835
| +3% | +$9.51M | 0.03% | 473 |
|
|
2023
Q4 | $270M | Buy |
1,146,009
+23,186
| +2% | +$4.56M | 0.03% | 486 |
|
|
2023
Q3 | $220M | Buy |
1,122,823
+21,423
| +2% | +$4.4M | 0.03% | 506 |
|
|
2023
Q2 | $231M | Buy |
1,101,400
+38,984
| +4% | +$7.76M | 0.03% | 500 |
|
|
2023
Q1 | $214M | Buy |
1,062,416
+25,019
| +2% | +$5.67M | 0.03% | 500 |
|
|
2022
Q4 | $226M | Buy |
1,037,397
+42,486
| +4% | +$9.28M | 0.03% | 474 |
|
|
2022
Q3 | $196M | Buy |
994,911
+26,168
| +3% | +$5.65M | 0.03% | 484 |
|
|
2022
Q2 | $207M | Buy |
968,743
+10,119
| +1% | +$2.47M | 0.03% | 485 |
|
|
2022
Q1 | $272M | Buy |
958,624
+33,886
| +4% | +$10.4M | 0.03% | 464 |
|
|
2021
Q4 | $348M | Buy |
924,738
+13,586
| +1% | +$5.28M | 0.04% | 410 |
|
|
2021
Q3 | $375M | Buy |
911,152
+35,148
| +4% | +$14.6M | 0.05% | 359 |
|
|
2021
Q2 | $323M | Buy |
876,004
+286,056
| +48% | +$95.5M | 0.04% | 396 |
|
|
2021
Q1 | $171M | Buy |
589,948
+26,620
| +5% | +$7.4M | 0.03% | 552 |
|
|
2020
Q4 | $141M | Buy |
563,328
+31,759
| +6% | +$7.56M | 0.02% | 572 |
|
|
2020
Q3 | $120M | Sell |
531,569
-23,376
| -4% | -$4.85M | 0.02% | 547 |
|
|
2020
Q2 | $96.8M | Buy |
554,945
+16,106
| +3% | +$2.57M | 0.02% | 584 |
|
|
2020
Q1 | $68M | Buy |
538,839
+17,751
| +3% | +$2.66M | 0.02% | 626 |
|
|
2019
Q4 | $79.6M | Buy |
521,088
+21,920
| +4% | +$3.03M | 0.02% | 702 |
|
|
2019
Q3 | $66.1M | Buy |
499,168
+8,348
| +2% | +$1.12M | 0.02% | 747 |
|
|
2019
Q2 | $69.6M | Buy |
490,820
+14,176
| +3% | +$1.92M | 0.02% | 716 |
|
|
2019
Q1 | $69.2M | Buy |
476,644
+19,115
| +4% | +$2.51M | 0.02% | 687 |
|
|
2018
Q4 | $51.8M | Buy |
457,529
+28,878
| +7% | +$3.62M | 0.02% | 714 |
|
|
2018
Q3 | $57.7M | Buy |
428,651
+5,024
| +1% | +$620K | 0.02% | 738 |
|
|
2018
Q2 | $47.6M | Sell |
423,627
-9,603
| -2% | -$1.04M | 0.01% | 786 |
|
|
2018
Q1 | $46.2M | Buy |
433,230
+617
| +0.1% | +$66.5K | 0.02% | 771 |
|
|
2017
Q4 | $47.3M | Buy |
432,613
+28,456
| +7% | +$3.1M | 0.02% | 726 |
|
|
2017
Q3 | $43.7M | Buy |
404,157
+28,908
| +8% | +$2.97M | 0.02% | 749 |
|
|
2017
Q2 | $38M | Buy |
375,249
+5,377
| +1% | +$495K | 0.01% | 787 |
|
|
2017
Q1 | $33.3M | Buy |
369,872
+30,490
| +9% | +$2.59M | 0.01% | 834 |
|
|
2016
Q4 | $25.9M | Buy |
339,382
+13,499
| +4% | +$1.03M | 0.01% | 913 |
|
|
2016
Q3 | $27.2M | Buy |
325,883
+13,597
| +4% | +$1.14M | 0.01% | 811 |
|
|
2016
Q2 | $25.7M | Buy |
312,286
+9,346
| +3% | +$770K | 0.01% | 795 |
|
|
2016
Q1 | $23K | Buy |
302,940
+32,224
| +12% | +$2.39M | 0.01% | 845 |
|
|
2015
Q4 | $21.8M | Sell |
270,716
-686
| -0.3% | -$49.5K | 0.01% | 842 |
|
|
2015
Q3 | $17.2M | Buy |
271,402
+12,746
| +5% | +$915K | 0.01% | 966 |
|
|
2015
Q2 | $18.2M | Sell |
258,656
-1,204
| -0.5% | -$89.1K | 0.01% | 988 |
|
|
2015
Q1 | $20.6M | Buy |
259,860
+14,070
| +6% | +$1.04M | 0.01% | 905 |
|
|
2014
Q4 | $15.6M | Sell |
245,790
-11,313
| -4% | -$709K | 0.01% | 1023 |
|
|
2014
Q3 | $15.4M | Sell |
257,103
-413
| -0.2% | -$23.6K | 0.01% | 983 |
|
|
2014
Q2 | $13.8M | Buy |
257,516
+20,274
| +9% | +$1.11M | 0.01% | 1068 |
|
|
2014
Q1 | $14.3M | Buy |
237,242
+19,029
| +9% | +$1.11M | 0.01% | 1009 |
|
|
2013
Q4 | $11.6M | Buy |
218,213
+21,527
| +11% | +$1.08M | 0.01% | 1093 |
|
|
2013
Q3 | $9.1M | Buy |
196,686
+9,379
| +5% | +$430K | 0.01% | 1137 |
|
|
2013
Q2 | $7.68M | Buy |
+187,307
| New | +$8.03M | 0.01% | 1124 |
|
Other funds holding CRL
VCM
VPM
AI
Geode Capital Management's CRL Position: Q2 2026 in Review
Geode Capital Management increased its Charles River Laboratories (CRL) stake by 0% in Q2 2026, buying an estimated $7.83K and bringing the position to 1,305,738 shares worth $296M. The position accounts for 0.02% of the portfolio, ranked #644.
Geode Capital Management first reported a position in CRL in Q2 2013 and has held it in 53 quarters since. The position peaked at $375M in Q3 2021. 521 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Geode Capital Management held 1,305,738 shares of Charles River Laboratories worth $296M as of Q2 2026.
- Geode Capital Management bought 44 Charles River Laboratories shares in Q2 2026, an estimated $7.83K.
- Charles River Laboratories made up 0.02% of Geode Capital Management's portfolio in Q2 2026, its #644 holding.
- Geode Capital Management first reported a position in Charles River Laboratories in Q2 2013 and has held it in 53 quarters since.
- Geode Capital Management's Charles River Laboratories position peaked at $375M in Q3 2021.
- 521 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.